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OBJECTIVES In this study using radiofrequency current and the electroanatomic mapping system CARTO,
four line designs were tested in 84 patients suffering from drug-refractory atrial fibrillation
(AFib).
BACKGROUND Prevention of AFib by trigger elimination within the pulmonary veins (PVs) has been recently
reported, but the success may be lesser in patients with chronic AFib or large atria requiring
linear lesion deployment.
METHODS Type A encircled the ostia of all four PVs with a connection to the mitral annulus (MA). In
type B, three lines connected anatomic barriers. Type C encircled both septal and lateral PVs
with connections between PVs and to the MA. Type D encircled PVs only. In the initial 12
patients (type D/1), line validation was performed without, and in 23 patients (type D/2)
with, an additional catheter inside the encircled PVs.
RESULTS The ability to achieve completeness of all intended lines was 5% in type A, 21% in type B,
29% in C, 66% in type D/1, and 61% in type D/2. This resulted in stable sinus rhythm in 19%
(4/21 patients) in type A, 32% (6/19 patients) in type B, 50% (7/14 patients) in type C, 58%
(7/12 patients) in type D/1, and 65% (15/23 patients) in type D/2, respectively, over a mean
follow-up of 620  376 days. Besides thromboembolic events (one stroke and one transient
ischemic attack), total occlusion of a PV was a major complication in one patient, and acute
tamponade in two patients.
CONCLUSIONS Complete lesions in the left atrium were difficult to achieve using conventional radiofrequency
current technology, but were associated with sinus rhythm in 74% of patients during
long-term follow-up, whereas incomplete lesions led mostly to recurrences of AFib or
gap-related atrial tachycardia. (J Am Coll Cardiol 2003;42:1271–82) © 2003 by the
American College of Cardiology Foundation
Catheter ablation of atrial fibrillation (AFib) has been
attempted by either elimination of the initiating trigger or
by modifying the substrate for maintenance of the arrhyth-
mia. Prevention of AFib by trigger elimination within the
pulmonary veins (PVs) can be successful in up to 71% of
patients (1–3). The success rate may be lower in patients
with chronic AFib or large atria mostly due to extra-PV
See page 1283
triggers that cannot be ablated during electrophysiological
study. Therefore, substrate modification may be mandatory
either as primary or as additional treatment after successful
isolation of the PVs. We have recently shown that multiple
linear lesions may be successfully deployed within the right
atrium (RA), but do not prevent AFib episodes in the vast
majority of patients (4).
Compartmentalization of the left atrium (LA) by surgi-
cally deployed linear lesions has prevented AFib episodes
(5,6). Application of linear lesions within the LA by
catheter techniques has been reported with variable success
(7,8). In those reports, completeness of lines was not
validated in detail. Thus, it was unclear whether AFib
recurrences were due to incomplete lines or an inadequate
line design. Furthermore, incomplete linear lesions predis-
pose to gap-related tachycardia (AT) (9).
This paper presents four different line designs within the
LA aiming at modification of the myocardial substrate for
AFib and/or isolation of PVs in humans.
METHODS
Patient population. Between June 1997 and August 2000,
a total of 84 patients (66 male; mean age, 58.3  8.7 years)
underwent primary catheter ablation for AFib in the LA.
All patients suffered from either intermittent or chronic
symptomatic (n  15) AFib for a mean duration of 10  8
years and were refractory to a median number of four
antiarrhythmic agents (including amiodarone in 64 pa-
tients). A total of 46 patients had undergone previous
ablation procedures that failed to change their arrhythmia:
34 patients an RA linear lesion ablation for AFib, three
patients a PV isolation attempt using ultrasound energy,
nine patients a bidirectional isthmus blockade for atrial
flutter. All patients suffered from symptomatic AFib pre-
senting with symptoms such as palpitations, dizziness, or
presyncope despite antiarrhythmic treatment. The ethical
committee in Freiburg, Germany, had approved the study
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protocol, and all patients gave their written consent. After
exclusion of intracardiac thrombi by transesophageal echo-
cardiography, patients were studied in a fasting state under
continuous sedation.
Electrophysiologic study. Two standard catheters were
positioned: a His bundle recording catheter (Parahis, Bio-
sense Webster, Waterloo, Belgium) advanced via femoral
vein access, as well as a multipolar catheter (A 20, Biosense
Webster) advanced in the distal coronary sinus (CS) via the
left subclavian vein. Subsequently, trans-septal access using
a modified Brockenbrough technique was performed and
either a single standard 8F sheath (SL1, DAIG, St. Jude
Medical, Minnetonka, Minnesota) or a custom-made 11F
double sheath system (Cordis Roden, Roden, the Nether-
lands) was advanced. Using this double-sheath technique
(in nine patients of group A and B), the inner preformed
sheath guides the catheter tip so that it is in parallel and not
tangential orientation to the atrial wall and can be gently
dragged along the intended line (10). In type D/2 ablation
procedures, a double trans-septal puncture with two 8F
sheaths was performed. After trans-septal puncture, acti-
vated clotting time was adjusted to 250 to 300 s by repeat
intravenous.
Heparin bolus throughout the procedure. In addition, a
continuous infusion with heparinized saline was connected
to the trans-septal sheaths (flow rate 15 ml/h) to avoid
thrombus formation or air embolism.
Three-dimensional mapping. The electroanatomic map-
ping system (CARTO) was used to reconstruct the LA,
which has been previously described in detail (11). In brief,
a 4-mm tip mapping and ablation catheter (NAVI-Star,
Biosense Webster) was advanced to the LA via the trans-
septal sheath. Mapping was performed during stable pacing
conditions from the CS or from the RA septum. In case of
AFib, sinus rhythm (SR) was restored by external cardio-
version. If DC shock failed, intravenous flecainide (up to 1.5
mg/kg body weight, n  12 patients) was administered and
cardioversion repeated. After completion of the mapping, all
endocardial potentials were manually annotated.
Ablation design. Type A consisted of two lines: a circular
lesion, which incorporated all PV ostia and a connection
from the encircling line (close to the inferior lateral PV) to
the mitral annulus (MA) (Fig. 1A). This concept copies the
“core” line of the surgical Maze procedure and interrupts by
the lateral connection to the MA the potential macroreentry
around the annulus.
Type B consisted of three lines: the first connecting the
superior septal to the superior lateral PV (roof line), the
second connecting the middle of the roof line to the anterior
MA, and the third connecting the roof line towards the
posterior MA leaving an intentional gap of 2 to 3 cm to
allow activation of the LA appendage (Fig. 1B). This design
investigates a pure substrate modification attempt without
any trigger elimination by PV isolation.
Type C consisted of two encircling lines around the septal
superior and inferior PV ostia as well as the lateral superior
and inferior PV ostia, respectively. In addition, linear
connections along the posterior wall between the two
encircling lines and towards the lateral MA were deployed
(Fig. 1C). This design combines both the PV isolation with
the substrate modification attempt to interrupt potential
reentry circuits between the PV segments and around the
MA.
Type D, as type C without the connections between the
PV encircling lines (Fig. 1D). After the experience of
incomplete lesion deployment in type C, the connections
were omitted to avoid iatronegic gap-related tachycardia.
Ablation. The linear lesions were applied by moving the
ablation catheter along the previously designed lines in
temperature-controlled mode (maximum temperature 55°C,
maximum duration of 180 s, maximum 50 W).
End point for radiofrequency current (RFC) delivery was
either the total elimination of the local potential or a
maximum of 180 s. In case of an impedance drop by10,
RFC energy was immediately stopped to prevent carbon-
ization at the catheter tip.
Line validation. Validation was performed by conven-
tional mapping criteria followed by a repeat three-
dimensional reconstruction while pacing either from CS or
RA septum.
In type A, complete lines lead to an isolation of the
encircled area, as previously described (10). The electroana-
tomic activation map showed a sudden change from early to
late activation along the ablation line and/or no potentials at
all within the isolated area. Conduction gaps were identified
by sites with single potentials and by local early activation
(Fig. 2A).
In type B, completion of the anterior line was character-
ized by an abrupt change of the activation sequence re-
corded from the multipolar catheter placed distally in the
CS while pacing from the RA septum (Fig. 2B). Further-
more, double potentials could be found along the lines when
pacing from sites opposite to the ablation line: from RA
septum for the anterior and posterior line and from the CS
for the LA roof line. Accordingly, the electroanatomic map
showed a sudden change of the local activation times.
In type C, isolation of the PV segments was defined by a
decrease of local voltage amplitude of 70% within the
isolated areas using the amplitude voltage feature of the
Abbreviations and Acronyms
AFib  atrial fibrillation
AT  atrial tachycardia
CS  coronary sinus
LA  left atrium/atrial
LAA  left atrial appendage
MA  mitral annulus
PV  pulmonary vein
RA  right atrium/atrial
RFC  radiofrequency current
SR  sinus rhythm
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CARTO system and a cut-off limit of 0.1 mV (12).
Completion of the connecting lesions in type C was
determined by pacing maneuvers from the proximal and
distal CS while recording double potentials along the
ablation lines (Fig. 2C).
In type D, two different approaches were used: in the
initial 12 patients (type D/1), successful encircling of the PV
segments was defined as in type C (Fig 2D). In the
remaining 23 patients (type D/2), an additional catheter
(ParaHis, Biosense Webster, Diamond Bar, California) was
placed inside the respective PV before lesion deployment to
demonstrate a PV spike potential on one or more bipolar
Figure 1. Intended line designs: anterior posterior projections of a mesh graph of the electroanatomic mapping system CARTO of an LA with the
pulmonary veins (PV) and the trans-septal sheath depicted as colored tubes. Ablation lines are depicted by multiple red dots. (A) A long encircling line
around all four PV ostia (roof line) and a connection to the lateral mitral annulus (MA). (B) Roof line between the right and left superior PV ostium. The
anterior line connects the middle of the roof line to the superior MA; the posterior line aims at the inferior MA with an intentional gap of approximately
3 cm. (C) Two encircling lines around the ostia of the superior and inferior PVs on both the septal and lateral sides. Additional connections between the
PV segments (posterior line), the lateral PV segment, and the MA. (D) Encircling lines around the PVs on both sides without additional connection lines.
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Figure 2. Line validation (A) pulmonary artery (PA) projection of an activation map of the electroanatomic mapping system in the patient with a single persisting gap in the lateral aspect of the posterior
line as depicted by the gradual change of colors at the site of the conduction gap. Complete lesions demonstrate double potential while constantly pacing from the coronary sinus (CS). Continued on next page.
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Figure 2 Continued. (B) Comparison of the pre- and post-ablation activation map in a left anterior oblique projection for type B. The right-hand panel
demonstrates the activation sequence along a multipolar catheter advanced in the distal CS while constantly pacing from the RA septal site. Please note
the prolongation of the activation time after complete anterior line deployment in the distal CS electrodes. Continued on next page.
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electrograms. Validation of the completeness of the encir-
cling PV isolation line was demonstrated by loss or disso-
ciation of the PV spikes (Fig. 2E).
Definitions. Lines were classified as being either complete,
having a single or multiple conduction gaps.
Upon completion of the post-ablation maps, a manual
contrast injection in the ostia of all PVs was performed after
type C and D line deployment to exclude acute PV stenosis.
Follow-up. All patients were initially followed on their
previous antiarrhythmic medication that was continued
throughout the ablation procedure. Anticoagulation was
advised with warfarin (international normalized ratio 2 to
3), or with aspirin (300 mg per day) if the patient refused to
take warfarin. One day after the procedure, a 12-lead
electrocardiogram (ECG), transthoracic echocardiography,
and a 24-h Holter recording were performed. These were
repeated after one, three, and six months by the referring
physicians or by the ablation center (where all data was
collected and reviewed). In case of stable SR after three
months, antiarrhythmic medication was discontinued. Pa-
Figure 2 Continued. (C) Post-ablation activation map after pulmonary vein (PV) isolation during pacing from the CS catheter shown in a PA projection.
Double potentials are marked with blue dots. Continued on next page.
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Figure 2 Continued. (D) Comparison of voltage in the pre- and post-ablation maps in a posterior-anterior projection of the LA. The voltage is depicted according to the color spectrum shown in the right
upper corner, ranging from low (0.1 mV, red) to high-voltage (1.5 mV, purple). Continued on next page.
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tients were advised to obtain a 12-lead ECG in case of
recurrent palpitations. After completion of the six-month
follow-up, patients were contacted and interviewed via
telephone at regular intervals. Patients were offered a re-
attempt at catheter ablation if AFib persisted.
Study end points. The primary end point was the complete
deployment of the intended ablation lines.
Secondary end points were either recurrences of symp-
tomatic or documented AFib, stable SR, and new-onset ATs.
Statistical analysis. Continuous variables are expressed as
mean  1 SD.
RESULTS
Procedural data. The 84 patients underwent a total of 107
procedures. The average procedure time was 8.4  1.7 h
from sheath insertion to sheath extraction. A mean duration
of 33.3  30.5 min of fluoroscopy was used, ranging from
up to 145 min (Patient 8) in the first 10 procedures to as low
as 7.1 min with increasing experience of the investigators. A
mean number of 43.2  15.3 radiofrequency applications
were deployed (Table 1).
Validation of line completeness and results of follow-up.
In type A, a mean number of 49.2 15.7 RFC applications
were delivered over a mean total line length of 202  32
mm (185  28 mm for the PV isolation segment) (Table 2,
Fig. 3). Complete lines were achieved in a single patient
(during the second ablation session). This resulted in the
creation of a silent area in the posterior part of the LA (10).
In a second patient, a single gap persisted despite multiple
radiofrequency applications at the inferior lateral part of the
LA (Fig. 2A). In the remaining patients, multiple conduc-
tion gaps persisted in the roof (12 patients) and septal (10
patients) lines.
During a mean follow-up of 974  408 days, the patient
with complete lines remained in SR without antiarrhythmic
medication. The patient with the single gap was in SR with
frequent atrial extrasystoles on antiarrhythmic medication.
Of the 18 patients with incomplete lines, only two were in
Figure 2 Continued. (E) Left-hand panel depicts the multipolar catheter in the right upper PV (RUPV) during contrast injection through the second
trans-septal sheath. The right panel demonstrates the loss of the PV spike potential (arrow) during radiofrequency current application. Surface lead II, as
well as a bipolar electrogram from the 4-mm ablation catheter (Mp), four bipolar electrograms of the PV catheter (from distal to proximal), and from the
proximal CS are shown. MA  mitral annulus.
Table 1. Overview of Patient Demographics and Procedural Data for Each Line Design
Type A Type B Type C Type D/1 Type D/2 Total
# of patients treated 21 20 (19 ablated) 14 12 23 84
# of procedures 27 20 16 14 30 107
Mean age (yrs) 60  6 56  10 62.1  6.4 54.2  9.6 62.1  6.4 58.3  8.7
Gender (M/F) 19/2 15/4 10/4 7/5 20/3 66/18
AFib duration 11.3  9 8.2  5.9 11.7  10 9.8  6.4 8.7  7.5 9.9  8.2
# of chronic AFib 3 4 4 0 5 15
# of intermittent AFib 18 16 10 12 18 69
Mean number of episodes/months 12  8 16  11 16  11 17  14 16  11 –
Mean duration of episodes (h) 21  23 20  19 21  20 20  16 26  23 –
Procedure duration (h) 8.7  1.6 8.8  2 9.4  0.8 7.3  1.5 7.7  1.8 8.4  1.7
Fluoroscopy (min) 63  44.1 29  11.8 19.3  8.4 15.7  6.2 23.2  9.9 33.3  30.5
# of RFC application 49.2  15.7 46.7  15.7 46.4  14.7 33.9  9.0 34.1  16.1 43.2  15.3
Total length of ablation line (mm) 202  32 177  23 309  96 188  36 215  39 –
Length of PV isolation line(s) (mm) 185  28 – septal: 109  28 septal: 101  16 septal: 114  16 –
lateral: 120  40 lateral: 96  20 lateral: 110  24
Numbers are given as mean  SD.
AFib  Atrial fibrillation; PV  pulmonary vein; RFC  radiofrequency current.
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SR, but 14 patients experienced recurrences of AFib (one
patient underwent a second ablation attempt with design
C). Two patients (with multiple gaps) presented with
incessant atrial macroreentrant tachycardia around the MA
and underwent subsequent successful ablation.
In type B (Fig. 3B), a mean number of 46.7  15.7 RFC
applications were given over a mean total line length of 177
 23 mm. All three lines could be successfully deployed in
four patients (in all these patients the custom-made double
sheaths were used). Despite multiple RFC applications,
conduction gaps persisted in 15/19 patients, at the roof line
in 11 patients and the anterior line in eight patients. During
follow-up (827  330 days), complete lines resulted in SR
with occasional atrial extrasystoles in three patients, whereas
the remaining patient changed from chronic to intermittent
AFib on antiarrhythmic medication. Only one patient with
incomplete lesions remained in SR; all other patients had
recurrences of AFib on their medication. Two patients
suffered from incessant LA macroreentrant tachycardia due
to persisting gaps in either the roof or anterior line and
underwent subsequent successful ablation.
In type C (Fig. 3C), a mean number of 46.4 14.7 RFC
applications were delivered over a mean line length of 308
96 mm (109 28 mm and 120  40 mm for the septal and
lateral PV isolation segment, respectively). Complete encir-
cling of the septal PV ostia was achieved in all 14 patients.
The lateral encircling line was incomplete in nine patients,
with conduction gaps located close to the base of the left
atrial appendage (LAA). The connections between the PV
segments towards the mitral annulus were incomplete in
seven patients. Overall, lines were complete in only four
patients, whereas, in the remaining 10 patients, multiple
conduction gaps persisted despite repeat RFC applications.
During a follow-up of 511  142 days, three of the four
patients with complete lines remained in SR without anti-
arrhythmic medication. Of the remaining patients, only two
were in SR, whereas six patients had recurrences of AFib.
Two patients with incomplete connections towards the MA
had incessant AT and underwent subsequent catheter abla-
tion.
In type D/1 (Fig. 3D), a mean number of 33.7  9.0
RFC applications were delivered over a mean total line
length of 188  36 mm (101  16 mm and 96  20 mm
for the septal and lateral PV isolation segment, respectively).
Complete encircling was achieved around the septal PVs in
all patients, around the lateral PVs in 7/12 patients. After
two repeat procedures, this segment was completed in one
more patient. During a follow-up of 400  126 days, four
of the eight patients with complete linear lesions were in
stable SR without antiarrhythmic medication, whereas four
patients had persistent AFib episodes despite continued
antiarrhythmic medication. Three of the four patients with
an incomplete lateral PV segment remained in SR.
In type D/2 (Fig. 3E), a mean number of 34.1  16.1
RFC applications were given over a mean total line length
of 215  39 mm (114  16 mm and 110  24 mm for the
septal and lateral PV segment, respectively). Complete PV
encircling was achieved in all but one patient for the septal
segment, but remained incomplete in 10/23 patients for the
lateral segment after the initial ablation procedure. In repeat
procedures this linear lesion was completed in four addi-
tional patients. During a mean follow-up of 324  140
days, 12/14 patients with complete lines remained in stable
SR, whereas only 3/9 patients with incomplete lines re-
mained arrhythmia-free.
Complications. In two patients (type A and B) trans-
septal puncture resulted in acute tamponade, requiring
immediate pericardiocentesis. One patient (type A) under-
went the same procedure four weeks later; the other shifted
to type C six months later. Although no impedance rise had
been evident during the ablation session, one patient (type
A) suffered a stroke, leading to vision disturbances within
48 h after the procedure, and one patient (type D/2) suffered
a transient ischemic attack (without morphologic changes in
sequential computed tomography scans). The symptoms
resolved gradually during follow-up. In one patient of group
Table 2. Follow-Up of Treated Patients With Regard to the Respective Ablation Type: Patients Are Categorized With Respect to
Results of Line Validation After the Final Ablation Session
Type A Type B Type C Type D/1 Type D/2
# of patients treated 21 20 (19 ablated) 14 12 23
# of procedures 27 20 16 14 30
Mean follow-up duration 974  408 827  330 511  142 400  126 324  140
Complete lines (n) with
rhythm outcome
1/20 4/19 4/14 8/12 14/23
1 pt SR 3 pts SR  AES 3 pts SR 4 pts SR 12 pts SR
1 pt i.AFib 1 pt AFib 4 pts AFib 2 pts AFib
Incomplete lines (n) with
rhythm outcome
19/20 15/19 10/14 4/12 9/23
3 pts SR (single gap:
SR  AES)
1 pt SR 2 pts SR 3 pts SR 3 pts SR
14 pts AFib 12 pts AFib 6 pts AFib 1 pt AFib 6 pts AFib
2 pts AT 2 pts AT 2 pts AT
AA-TX  antiarrhythmic medication; AES  atrial extrasystoles; AFib  atrial fibrillation; AT  atrial tachycardia; i.AFib  intermittent atrial fibrillation; pt  patient; SR
 sinus rhythm.
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D/2, a 40% stenosis of the right upper PV was demon-
strated at the end of the ablation session but remained
asymptomatic during follow-up. One patient of group D/1
developed shortness of breath (initially only on exertion)
after an uneventful follow-up period of six months. Because
of increasing hemoptysis, the patient underwent repeat
bronchoscopies and finally an explorative mediastinoscopy
for suspicion of bronchial neoplasm. After transfer to the
ablation center, transesophageal echocardiography did not
demonstrate any flow in the right upper PV. Direct angiog-
raphy depicted a totally occluded right upper PV, which was
subsequently recanalized and dilated. However, despite
Figure 3. (A to E) (alternative to Table 2) Follow-up of treated patients using the respective ablation type. Patients are categorized with respect to results
of line validation after the final ablation session. AA-TX  antiarrhythmic medication; AES  atrial extrasystoles; AFib  atrial fibrillation; AT  atrial
tachycardia; i. AFib  intermittent atrial fibrillation; SR  sinus rhythm.
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antiplatelet and anticoagulation therapy, re-stenosis oc-
curred, necessitating repeat balloon dilation and, finally,
stent implantation.
DISCUSSION
We have recently shown that linear lesions within the RA
can be successfully deployed and validated using the elec-
troanatomic mapping system (4).
In contrast with previously reported data (8,13), RA
linear lesions did not prevent AFib recurrences, even when
these lesions were complete. Therefore, this study focused
on the efficacy of linear lesions within the LA. As in the RA
study, the electroanatomic mapping system was used for
lesion deployment. Special care was taken on line validation
by conventional electrophysiologic criteria and the use of the
electroanatomic mapping system, which might explain the
difference in procedure time and RFC delivery in other
studies (8,12).
The first line design (type A) was intended to compart-
mentalize a large part of the LA including all four PVs, and,
thereby, copy the “core” line of the maze operation. This
long single ablation line could only be completed in one of
18 patients, who stayed in SR. All other patients were left
with incomplete lines. All except two had recurrences of
AFib or AT. The second line design (type B) was aiming
solely at the interruption of possible macro–re-entries
around anatomic barriers such as PV ostia or the MA.
However, the only line that could be completed in 15/19
patients (79%) was the anterior line. In contrast, the roof
line turned out to be very difficult, which was mostly due to
catheter instability. Catheter stability was enhanced by the
use of the double sheath technique allowing a parallel rather
than tangential catheter tip orientation at the roof line. As
before, complete lines were associated with freedom from
AFib recurrences. In type C, encircling of PV segments may
also eliminate triggers from within the PVs. Each ablation
segment had a shorter lesion length (approximately 11 cm)
and, thereby, was easier to achieve. Inability to encircle the
lateral PVs can be explained by the anatomic location of the
intended line between the ostium of the lateral PVs and the
base of the LAA (14). The connections were intended to
prevent possible macro–re-entry around the newly pre-
formed barriers and the MA. These connections were
extremely difficult to achieve and remained incomplete in a
large proportion of patients (50%), causing iatrogenic gap-
related tachycardia during follow-up.
Therefore, in type D, the additional connections between
the PVs were omitted. During follow-up in type D/1, the
validation criterion of the reduced signal amplitude (70%
reduction as compared with the pre-ablation map and a
cut-off value of 0.1 mV) proved not to be discriminative
because only 4/8 patients with complete PV lesions re-
mained in SR, whereas 3/4 patients with incomplete lesions
were also in SR. In type D/2, loss of the PV spike potential
as the ablation end point demonstrated an improved dis-
criminative power: 12/14 patients with complete linear
lesions stayed in SR, compared with only 3/9 patients with
incomplete lesions. In contrast, when the end point was only
amplitude reduction, no correlation was found between
completeness of lines and maintenance of SR. These find-
ings are not in agreement with previously published data
(12). Although there might be a small difference in the
ablation design (separate isolation of each PV as compared
with an encircling line around both upper and lower PVs),
RFC delivery is extremely short (15 to 30 s) and might not
even result in a transmural lesion or have an effect on
epicardially located autonomic nervous endings.
The high incidence of incomplete ablation lines using a
solid 4-mm tip electrode demands further technological
improvement. The use of custom-made sheaths improved
the catheter-tissue contact, especially at the roof line. Other
techniques, such as irrigated tip catheters, were not available
at the time of study, but may improve lesion deployment
significantly and lower the risk of thromboembolic compli-
cations, which was 2.4% in this study.
Although the ablation lines were designed to be at the
atrial side, PV occlusion occurred in one patient. Even using
the enhanced mapping and navigation tools of the electro-
anatomic mapping system, assessment of the complex three-
dimensional anatomy of the PV-LA junction is difficult,
and intrapulmonary ablation cannot be ruled out because
distinctive markers for the PV ostia are missing. Even more
disturbing, PV occlusion developed slowly. The symptoms
such as hemoptysis and shortness of breath were, in our
patient, not related to the ablation procedure by the initially
involved physicians and led to numerous procedures before
the diagnosis of PV occlusion was made.
Study limitations. The evidence of complete linear lesions
at the end of the ablation session may only be a transient
phenomenon, and re-conduction may occur during follow-
up, which may account for recurrences, although complete
lines were acutely demonstrated. On the other hand, RFC-
induced lesions may mature after the ablation session,
accounting for the effective treatment of patients defined as
“incomplete.” Finally, the growing experience of the inves-
tigators in deploying linear lesions in the LA using sequen-
tial RFC applications have to be taken into account when
judging the effectiveness of the line designs.
Conclusions. Complete lesions in the LA were difficult to
achieve using conventional RFC technology, but were
associated with SR in 74% of patients during long-term
follow-up, whereas incomplete lesions led mostly to recur-
rences of AFib or gap-related AT. Further technological
improvement (catheter design, ablation energy, specifically
designed trans-septal sheaths) is necessary to improve line
completeness and to facilitate line deployment.
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